Gemcitabine-Based Chemoradiotherapy Gets Improved with PARP Inhibitor in Pancreatic Cancer Cells. - Waissi, W.; Burckel, H.; Nicol, A.; Larderet, G.; Noel, G. (International Journal of Radiation Oncology, Biology, Physics, 2018)